301 related articles for article (PubMed ID: 18300297)
1. Quality by design, part I: application of NIR spectroscopy to monitor tablet manufacturing process.
Tabasi SH; Fahmy R; Bensley D; O'Brien C; Hoag SW
J Pharm Sci; 2008 Sep; 97(9):4040-51. PubMed ID: 18300297
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of the manufacturing process for ambroxol hydrochloride tablet using NIR-chemometric methods: compression effect on content uniformity model and relevant process parameters testing.
Yang H; Liao X; Peng F; Wang W; Liu Y; Yan J; Li H
Drug Dev Ind Pharm; 2015; 41(11):1877-87. PubMed ID: 25738811
[TBL] [Abstract][Full Text] [Related]
3. Assessment of NIR spectroscopy for nondestructive analysis of physical and chemical attributes of sulfamethazine bolus dosage forms.
Tatavarti AS; Fahmy R; Wu H; Hussain AS; Marnane W; Bensley D; Hollenbeck G; Hoag SW
AAPS PharmSciTech; 2005 Sep; 6(1):E91-9. PubMed ID: 16353969
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting.
Khorasani M; Amigo JM; Sun CC; Bertelsen P; Rantanen J
Eur J Pharm Biopharm; 2015 Jun; 93():293-302. PubMed ID: 25917640
[TBL] [Abstract][Full Text] [Related]
5. Towards a real time release approach for manufacturing tablets using NIR spectroscopy.
Pestieau A; Krier F; Thoorens G; Dupont A; Chavez PF; Ziemons E; Hubert P; Evrard B
J Pharm Biomed Anal; 2014 Sep; 98():60-7. PubMed ID: 24880992
[TBL] [Abstract][Full Text] [Related]
6. Applications of NIR in early stage formulation development. Part II. Content uniformity evaluation of low dose tablets by principal component analysis.
Li W; Bagnol L; Berman M; Chiarella RA; Gerber M
Int J Pharm; 2009 Oct; 380(1-2):49-54. PubMed ID: 19576977
[TBL] [Abstract][Full Text] [Related]
7. End point determination of blending process for trimebutine tablets using principle component analysis (PCA) and partial least squares (PLS) regression.
Lee SH; Lee JH; Cho S; Do SH; Woo YA
Arch Pharm Res; 2012 Sep; 35(9):1599-607. PubMed ID: 23054717
[TBL] [Abstract][Full Text] [Related]
8. Quality-by-design III: application of near-infrared spectroscopy to monitor roller compaction in-process and product quality attributes of immediate release tablets.
Kona R; Fahmy RM; Claycamp G; Polli JE; Martinez M; Hoag SW
AAPS PharmSciTech; 2015 Feb; 16(1):202-16. PubMed ID: 25319052
[TBL] [Abstract][Full Text] [Related]
9. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
Tabasi SH; Moolchandani V; Fahmy R; Hoag SW
Int J Pharm; 2009 Dec; 382(1-2):1-6. PubMed ID: 19660535
[TBL] [Abstract][Full Text] [Related]
10. In-line monitoring of the drug content of powder mixtures and tablets by near-infrared spectroscopy during the continuous direct compression tableting process.
Järvinen K; Hoehe W; Järvinen M; Poutiainen S; Juuti M; Borchert S
Eur J Pharm Sci; 2013 Mar; 48(4-5):680-8. PubMed ID: 23313622
[TBL] [Abstract][Full Text] [Related]
11. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature.
Dave VS; Fahmy RM; Hoag SW
Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574
[TBL] [Abstract][Full Text] [Related]
12. Blend uniformity end-point determination using near-infrared spectroscopy and multivariate calibration.
Sulub Y; Konigsberger M; Cheney J
J Pharm Biomed Anal; 2011 Jun; 55(3):429-34. PubMed ID: 21398064
[TBL] [Abstract][Full Text] [Related]
13. Development of a method for the determination of caffeine anhydrate in various designed intact tablets [correction of tables] by near-infrared spectroscopy: a comparison between reflectance and transmittance technique.
Ito M; Suzuki T; Yada S; Kusai A; Nakagami H; Yonemochi E; Terada K
J Pharm Biomed Anal; 2008 Aug; 47(4-5):819-27. PubMed ID: 18508223
[TBL] [Abstract][Full Text] [Related]
14. High-throughput NIR-chemometric methods for chemical and pharmaceutical characterization of sustained release tablets.
Porfire A; Filip C; Tomuta I
J Pharm Biomed Anal; 2017 May; 138():1-13. PubMed ID: 28171787
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of NIR-chemometric methods for chemical and pharmaceutical characterization of meloxicam tablets.
Tomuta I; Iovanov R; Bodoki E; Vonica L
Drug Dev Ind Pharm; 2014 Apr; 40(4):549-59. PubMed ID: 23594301
[TBL] [Abstract][Full Text] [Related]
16. In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process.
Karande AD; Heng PW; Liew CV
Int J Pharm; 2010 Aug; 396(1-2):63-74. PubMed ID: 20558264
[TBL] [Abstract][Full Text] [Related]
17. High-throughput NIR-chemometric methods for determination of drug content and pharmaceutical properties of indapamide tablets.
Tomuta I; Rus L; Iovanov R; Rus LL
J Pharm Biomed Anal; 2013 Oct; 84():285-92. PubMed ID: 23347649
[TBL] [Abstract][Full Text] [Related]
18. Strategic development of a multivariate calibration model for the uniformity testing of tablets by transmission NIR analysis.
Sasakura D; Nakayama K; Sakamoto T; Chikuma T
Pharmazie; 2015 May; 70(5):289-95. PubMed ID: 26062295
[TBL] [Abstract][Full Text] [Related]
19. NIR spectroscopy applications in the development of a compacted multiparticulate system for modified release.
Cantor SL; Hoag SW; Ellison CD; Khan MA; Lyon RC
AAPS PharmSciTech; 2011 Mar; 12(1):262-78. PubMed ID: 21240575
[TBL] [Abstract][Full Text] [Related]
20. High-throughput prediction of tablet weight and trimethoprim content of compound sulfamethoxazole tablets for controlling the uniformity of dosage units by NIR.
Dong Y; Li J; Zhong X; Cao L; Luo Y; Fan Q
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Apr; 159():78-82. PubMed ID: 26828535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
